The Science of NAD+ and Cellular Energy

What NAD+ Actually Does

NAD+ functions primarily as an electron carrier in cellular metabolism. In the mitochondria — the organelles responsible for producing ATP, the cell's energy currency — NAD+ accepts electrons from metabolic reactions and ferries them through the electron transport chain. Without adequate NAD+, this process slows. Cells produce less energy. Tissues begin to underperform.

But NAD+ is far more than a fuel transport molecule. It is also the essential substrate for two families of enzymes with direct roles in longevity and disease resistance:

• Sirtuins (SIRT1–SIRT7)— a family of NAD+-dependent deacetylases that regulate gene expression, inflammation, stress resistance, and mitochondrial biogenesis. Sirtuins have been described by researcher David Sinclair (Harvard Medical School) as central "longevity genes." SIRT1 and SIRT3 in particular are strongly linked to metabolic health and cellular stress response. Without sufficient NAD+, sirtuin activity drops substantially.
• PARPs (Poly ADP-ribose polymerases)— enzymes that consume NAD+ to detect and repair DNA strand breaks. As DNA damage accumulates with age, PARP activity increases, accelerating NAD+ depletion. This creates a cycle: more damage leads to more PARP activity, which depletes NAD+, which reduces sirtuin function, which reduces the cell's ability to maintain genomic integrity.

How NAD+ Declines with Age

Research consistently shows that NAD+ levels fall significantly across the human lifespan. A landmark study published in Cell Metabolism (Yoshino et al., 2018) documented that NAD+ levels in skeletal muscle decline approximately 50% between ages 40 and 60. The rate of decline is not uniform — it accelerates with metabolic stress, chronic inflammation, poor sleep, alcohol consumption, and sedentary behavior.

The primary driver of this decline is multifactorial:

• Reduced biosynthesis — the body's ability to synthesize NAD+ from tryptophan and niacin decreases with age.
• Increased NAD+ consumption — PARP enzymes and CD38 (an enzyme that breaks down NAD+) both upregulate with inflammation and aging.
• Reduced salvage pathway activity — the recycling of nicotinamide back into NAD+ via NAMPT (nicotinamide phosphoribosyltransferase) becomes less efficient.

NAD+ Precursors: NMN and NR

Because NAD+ itself does not effectively cross cell membranes, researchers have focused on its precursors — compounds the body converts into NAD+. The two most studied are:

• NR (Nicotinamide Riboside) — a form of vitamin B3 first shown to raise NAD+ levels in human blood in a 2004 study by Brenner et al. in Cell Metabolism. A 2016 randomized controlled trial in Nature Communications (Trammell et al.) confirmed that oral NR supplementation significantly increased NAD+ in healthy adults, with no serious adverse effects observed.
• NMN (Nicotinamide Mononucleotide)— a direct precursor to NAD+ in the salvage pathway. Animal studies from David Sinclair's laboratory (published in Cell, 2013) demonstrated that NMN administration in aging mice restored NAD+ levels, improved mitochondrial function, and reversed some markers of vascular aging. A 2022 randomized, double-blind, placebo-controlled trial in Nature Aging(Igarashi et al.) showed that 12 weeks of oral NMN in healthy older adults raised NAD+ metabolites and improved muscle performance.

It is important to note that while preclinical data is compelling, human clinical trials remain ongoing. The field is actively evolving, and dose optimization, long-term safety, and clinical endpoint data are still being established.

What This Means Clinically

Restoring NAD+ levels is not a simple intervention — it requires understanding each patient's baseline, their metabolic state, and the specific pathways most relevant to their symptoms and goals. At CÉLURE, NAD+ optimization is considered in the context of a full biomarker panel, not as a standalone supplement recommendation.

Clinically relevant questions include: what is driving NAD+ depletion in this individual? Is it chronic inflammation (elevating CD38)? DNA damage burden? Poor sleep or metabolic dysfunction? The answer changes the approach. Supporting NAD+ may involve precursor supplementation, lifestyle modifications that reduce unnecessary consumption, or protocols that enhance mitochondrial biogenesis — often in combination.

The goal is not simply to raise a number. It is to restore a biological environment in which the sirtuin network, mitochondrial function, and DNA integrity can operate closer to their optimal capacity.